摘要
目的 调查分析某医院门诊口服中成药使用情况,为临床合理用药提供参考.方法 随机抽取2023年某医院门诊口服中成药处方,统计中成药剂型、处方来源、联合用药、用药频率前20名情况.结果 门诊口服中成药剂型以胶囊、片剂为主.处方来源占比由高到低为急诊科、骨科、心血管内科、便民门诊、呼吸科等.口服中成药以藤黄健骨片、连花清瘟颗粒、强力枇杷露等使用较频繁.门诊不合格处方以不适宜占比发生最高,其次为不规范处方、超常处方.结论 门诊口服中成药使用不合理情况较多,在以后的工作中仍需进一步规范口服中成药的使用,促进合理用药.
Abstract
Objective To investigate the use of oral Chinese patent medicines among outpatients in order to provide references for rational drug use in the clinic.Methods Prescriptions for oral Chinese patent medicines given by the outpatient department in 2023 were randomly selected before the data on dosage forms,sources of prescriptions,combinations of drugs,and the top 20 drugs used was collected.Results The dosage forms were primarily capsules and tablets.The biggest source of prescriptions was the Department of Emergency,followed by the Department of Orthopedics,Department of Cardiology,the outpatient clinic,and Department of Respiratory Medicine.Tenghuangjiangu Tablets,Lianhuaqingwen granules,and Qianglipipa liquid were among the most frequently prescribed medicines.The most com-mon issue identified was inappropriate prescriptions,followed by substandard and off-label prescriptions.Conclusion The use of oral Chinese patent medicines in the outpatient department is sometimes irrational,so more regulation is needed to promote rational drug use.
NETL
NSTL
万方数据